Max Moldovan
Overview
Explore the profile of Max Moldovan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
1635
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sluggett J, Caughey G, Air T, Lang C, Moldovan M, Martin G, et al.
Res Social Adm Pharm
. 2024 Aug;
20(11):1064-1069.
PMID: 39187425
Background: The impact of Home Medicines Reviews (HMRs) on long-term health outcomes among individuals receiving long-term in-home aged care services is unknown. Objectives: To examine associations between HMR provision and...
2.
Eshetie T, Moldovan M, Caughey G, Lang C, Sluggett J, Khadka J, et al.
J Am Med Dir Assoc
. 2023 Jan;
24(3):299-306.e9.
PMID: 36603825
Objectives: Although largely preventable, pressure injury is a major concern in individuals in permanent residential aged care (PRAC). Our study aimed to identify predictors and develop a prognostic model for...
3.
Sluggett J, Caughey G, Air T, Moldovan M, Lang C, Martin G, et al.
Age Ageing
. 2022 Jul;
51(7).
PMID: 35794851
Background: no studies have examined the impact of residential medication management review (RMMR, a 24-year government subsidised comprehensive medicines review program) in Australian residential aged care facilities (RACFs) on hospitalisation...
4.
Sluggett J, Caughey G, Air T, Moldovan M, Lang C, Martin G, et al.
BMC Geriatr
. 2022 Jun;
22(1):493.
PMID: 35676644
Background: Residential Medication Management Review (RMMR) is a subsidized comprehensive medicines review program for individuals in Australian residential aged care facilities (RACFs). This study examined weekly trends in medicines use...
5.
Centenera M, Vincent A, Moldovan M, Lin H, Lynn D, Horvath L, et al.
Cancers (Basel)
. 2022 Apr;
14(7).
PMID: 35406480
Prostate cancer is a complex and heterogeneous disease, but a small number of cell lines have dominated basic prostate cancer research, representing a major obstacle in the field of drug...
6.
Jiang S, Mercan S, Papa I, Moldovan M, Walters G, Koina M, et al.
Cell Rep Med
. 2022 Jan;
2(12):100475.
PMID: 35028616
We identify an intronic deletion in that predisposes to renal injury in high risk populations through a kidney-intrinsic process. Half of all SLE patients develop nephritis, yet the predisposing mechanisms...
7.
Inacio M, Moldovan M, Whitehead C, Sluggett J, Crotty M, Corlis M, et al.
BMC Geriatr
. 2021 Dec;
21(1):686.
PMID: 34876037
Background: Entering permanent residential aged care (PRAC) is a vulnerable time for individuals. While falls risk assessment tools exist, these have not leveraged routinely collected and integrated information from the...
8.
Gillis J, Hinneh J, Ryan N, Irani S, Moldovan M, Quek L, et al.
Elife
. 2021 Aug;
10.
PMID: 34382934
Alterations to the androgen receptor (AR) signalling axis and cellular metabolism are hallmarks of prostate cancer. This study provides insight into both hallmarks by uncovering a novel link between AR...
9.
Butler L, Mah C, Machiels J, Vincent A, Irani S, Mutuku S, et al.
Cancer Res
. 2021 Aug;
81(19):4981-4993.
PMID: 34362796
Dysregulated lipid metabolism is a prominent feature of prostate cancer that is driven by androgen receptor (AR) signaling. Here we used quantitative mass spectrometry to define the "lipidome" in prostate...
10.
Sluggett J, Moldovan M, Lang C, Lynn D, Papanicolas L, Crotty M, et al.
J Antimicrob Chemother
. 2021 Feb;
76(5):1339-1348.
PMID: 33580681
Objectives: To examine national variation in systemic antibiotic use in long-term care facilities (LTCFs) and identify facility characteristics associated with antibiotic utilization. Methods: This retrospective cohort study included 312 375...